Background: Active individuals with transfemoral amputations are provided a microprocessor-controlled knee with the belief that the prosthesis reduces their risk of falling. However, these prostheses are expensive and the costeffectiveness is unknown with regard to falls in the transfemoral amputation population. The direct medical costs of falls in adults with transfemoral amputations need to be determined in order to assess the incremental costs and benefits of microprocessor-controlled prosthetic knees. Objective: We describe the direct medical costs of falls in adults with a transfemoral amputation. Study design: This is a retrospective, population-based, cohort study of adults who underwent transfemoral amputations between 2000 and 2014. Methods: A Bayesian structural time series approach was used to estimate cost differences between fallers and non-fallers. Results: The mean 6-month direct medical costs of falls for six hospitalized adults with transfemoral amputations was US$25,652 (US$10,468, US$38,872). The mean costs for the 10 adults admitted to the emergency department was US$18,091 (US$-7,820, US$57,368). Conclusion: Falls are expensive in adults with transfemoral amputations. The 6-month costs of falls resulting in hospitalization are similar to those reported in the elderly population who are also at an increased risk of falling. Clinical relevance Estimates of fall costs in adults with transfemoral amputations can provide policy makers with additional insight when determining whether or not to cover a prescription for microprocessor-controlled prosthetic knees.
- Bayesian analysis
- Cost analysis
ASJC Scopus subject areas
- Health Professions (miscellaneous)